1.0
Feb 13, 2014
Recommend
CEO approval
Business Outlook
Pros
used to be benefits, but not any longer
Cons
micro management, lack of SOPs and process guidance. No integrity in the drug development process. Individual departments work like a CRO, trying to please their customers while violating SOPs, FDA guidelines and ICH.